Changchun High & New Technology Industries Group Inc - Asset Resilience Ratio

Latest as of September 2025: 3.73%

Changchun High & New Technology Industries Group Inc (000661) has an Asset Resilience Ratio of 3.73% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Changchun High & New Technology Industri debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.17 Billion
≈ $171.55 Million USD Cash + Short-term Investments

Total Assets

CN¥31.46 Billion
≈ $4.60 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1996–2024)

This chart shows how Changchun High & New Technology Industries Group Inc's Asset Resilience Ratio has changed over time. See 000661 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Changchun High & New Technology Industries Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000661 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.17 Billion 3.73%
Total Liquid Assets CN¥1.17 Billion 3.73%

Asset Resilience Insights

  • Limited Liquidity: Changchun High & New Technology Industries Group Inc maintains only 3.73% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Changchun High & New Technology Industries Group Inc Industry Peers by Asset Resilience Ratio

Compare Changchun High & New Technology Industries Group Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd
KQ:023910
Drug Manufacturers - Specialty & Generic 11.95%
Aurobindo Pharma Limited
NSE:AUROPHARMA
Drug Manufacturers - Specialty & Generic 16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
Drug Manufacturers - Specialty & Generic 5.22%
Ningbo Menovo Pharm Co Ltd
SHG:603538
Drug Manufacturers - Specialty & Generic 2.69%
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332
Drug Manufacturers - Specialty & Generic 6.02%
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
Drug Manufacturers - Specialty & Generic 30.38%
Hainan Honz Pharmaceutical Co
SHE:300086
Drug Manufacturers - Specialty & Generic 0.27%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%

Annual Asset Resilience Ratio for Changchun High & New Technology Industries Group Inc (1996–2024)

The table below shows the annual Asset Resilience Ratio data for Changchun High & New Technology Industries Group Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.08% CN¥24.96 Million
≈ $3.65 Million
CN¥31.05 Billion
≈ $4.54 Billion
+0.05pp
2023-12-31 0.03% CN¥9.96 Million
≈ $1.46 Million
CN¥30.74 Billion
≈ $4.50 Billion
+0.39pp
2022-12-31 -0.36% CN¥-93.39 Million
≈ $-13.67 Million
CN¥26.03 Billion
≈ $3.81 Billion
+0.22pp
2021-12-31 -0.57% CN¥-129.31 Million
≈ $-18.92 Million
CN¥22.52 Billion
≈ $3.29 Billion
-0.64pp
2020-12-31 0.06% CN¥10.28 Million
≈ $1.50 Million
CN¥16.91 Billion
≈ $2.47 Billion
-1.64pp
2019-12-31 1.70% CN¥215.86 Million
≈ $31.59 Million
CN¥12.72 Billion
≈ $1.86 Billion
-4.72pp
2018-12-31 6.41% CN¥605.00 Million
≈ $88.53 Million
CN¥9.43 Billion
≈ $1.38 Billion
-6.78pp
2017-12-31 13.19% CN¥970.00 Million
≈ $141.94 Million
CN¥7.35 Billion
≈ $1.08 Billion
-10.82pp
2016-12-31 24.02% CN¥1.49 Billion
≈ $218.03 Million
CN¥6.20 Billion
≈ $907.77 Million
+25.43pp
2015-12-31 -1.41% CN¥-53.95 Million
≈ $-7.89 Million
CN¥3.82 Billion
≈ $558.33 Million
-1.42pp
2014-12-31 0.01% CN¥179.55K
≈ $26.27K
CN¥3.15 Billion
≈ $460.71 Million
+4.31pp
2008-12-31 -4.30% CN¥-66.57 Million
≈ $-9.74 Million
CN¥1.55 Billion
≈ $226.45 Million
+0.75pp
2007-12-31 -5.05% CN¥-76.39 Million
≈ $-11.18 Million
CN¥1.51 Billion
≈ $221.22 Million
-5.07pp
2005-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.41 Billion
≈ $206.88 Million
0.00pp
2004-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.39 Billion
≈ $203.99 Million
+0.00pp
2003-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.55 Billion
≈ $226.98 Million
-0.01pp
2002-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.22 Billion
≈ $178.72 Million
+0.02pp
1998-12-31 0.01% CN¥87.65K
≈ $12.83K
CN¥1.30 Billion
≈ $190.46 Million
-0.54pp
1996-12-31 0.54% CN¥4.00 Million
≈ $584.70K
CN¥737.35 Million
≈ $107.90 Million
--
pp = percentage points

About Changchun High & New Technology Industries Group Inc

SHE:000661 China Drug Manufacturers - Specialty & Generic
Market Cap
$5.07 Billion
CN¥34.65 Billion CNY
Market Cap Rank
#3556 Global
#549 in China
Share Price
CN¥84.93
Change (1 day)
-0.62%
52-Week Range
CN¥83.76 - CN¥136.30
All Time High
CN¥1174.87
About

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers genetic engineering, biological vaccines, antibody drugs, chemical drugs, and modern Chinese medicine. It also develops real estate properties. The company was founded in 1993 and is… Read more